Invo Bioscience Inc Reports Results For The Quarter Ended In March: Earnings Summary

INVO Fertility

17/05/2021 22:07

* INVO Bioscience Inc  INVO.OQ  reported a quarterly adjusted
loss of 25 cents​​ per share for the quarter ended in March. The
mean expectation of two analysts for the quarter was for a loss
of 17 cents per share.
* Revenue was $684.00 thousand​;  analysts expected $593.00
thousand. 
* The mean earnings estimate of analysts had fallen by
about 2.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* INVO Bioscience Inc shares had fallen by 9.2% this quarter and
gained 30.6% so far this year.
* Wall Street's median 12-month price target for INVO Bioscience
Inc is $5.88 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 17 at 09:07 p.m. GMT.
​All figures in US dollars